Valeant Pharmaceuticals International develops and markets medications used in the fields of neurology, dermatology and infectious diseases. read more
Valeant Pharmaceuticals International VP of Investor Relations Salary
$77k
$120k
$129k
$225k
N/A
Average Compensation
VP of Investor Relations Salaries at Valeant Pharmaceuticals International
Compensation at Valeant Pharmaceuticals International by Department
The Communications Department averages $17,064 more than the Enterprise Risk Department.
Communications
$192,901 Enterprise Risk
$175,837 -$17k
Product
$162,740 -$30k
How VPs of Investor Relations at Valeant Pharmaceuticals International Rate Their Compensation
The majority of VPs of Investor Relations at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of VPs of Investor Relations at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International
VP of Investor Relations Salaries at Similar Size Companies
×